{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:43:04Z","timestamp":1771674184793,"version":"3.50.1"},"reference-count":68,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1517\/14796694.1.3.395","type":"journal-article","created":{"date-parts":[[2005,7,7]],"date-time":"2005-07-07T13:47:27Z","timestamp":1120744047000},"page":"395-403","source":"Crossref","is-referenced-by-count":10,"title":["Anti-Thrombotics in Thrombosis and Cancer"],"prefix":"10.1080","volume":"1","author":[{"given":"Shaker A","family":"Mousa","sequence":"first","affiliation":[{"name":"Director of Pharmaceutical Research Institute (PRI) at Albany,Professor of Albany College of Pharmacy,\r106 New Scotland Avenue\rAlbany,\rNY\r12208-3492,\rUSA. Tel.: ; Fax.: ;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2005,11,24]]},"reference":[{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-20559"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-9492"},{"key":"e_1_3_1_5_1","first-page":"161","article-title":"The metastatic process: basic research and clinical implications","volume":"11","author":"Chambers AF","year":"1999","unstructured":"Chambers AF : The metastatic process: basic research and clinical implications. Oncol. Res.11,161\u2013168 (1999).","journal-title":"Oncol. Res."},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00690599"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.061615598"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1509"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2001000600003"},{"key":"e_1_3_1_10_1","first-page":"94","volume-title":"Clinique de l\u2018Hotel-Dieu de Paris","author":"Trousseau A","year":"1865","unstructured":"Trousseau A : Phlegmasia alba dolens. In: Clinique de l\u2018Hotel-Dieu de Paris, 2nd Edn BaillierJB (Ed.) London, New Sydenham Society3, 94 (1865).","edition":"2"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.5414\/CPP40329"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012213432504"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(02)00871-9"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940701)74:1<38::AID-CNCR2820740108>3.0.CO;2-E"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.8.993"},{"key":"e_1_3_1_16_1","first-page":"43","volume-title":"Protective Agents in Cancer","author":"Thornes R","year":"1983","unstructured":"Thornes R : Coumarins, melanoma and cellular immunity. In: Protective Agents in Cancer. McBrienD, SlatorT (Eds), Academic Press, UK, 43\u201356 (1983)."},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10269"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370020071039"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)10018-6"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V62.1.14.14"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1657515"},{"key":"e_1_3_1_22_1","first-page":"50","article-title":"Mechanisms of hypercoagulation in malignancy and during chemotherapy.","volume":"28","author":"Falanga A","year":"1998","unstructured":"Falanga A : Mechanisms of hypercoagulation in malignancy and during chemotherapy.Haemostasis28,50\u201360 (1998).","journal-title":"Haemostasis"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91690-3"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709043371002"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603143341102"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613311"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V101.5.1970"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365510260296492"},{"key":"e_1_3_1_29_1","doi-asserted-by":"crossref","unstructured":"Verheul HM PinedoHM: Tumor growth: a putative role for platelets? Oncologist3 II (1998).","DOI":"10.1634\/theoncologist.3-2-0"},{"key":"e_1_3_1_30_1","first-page":"2187","article-title":"Platelet: transporter of vascular endothelial growth factor","volume":"3","author":"Verheul HM","year":"1997","unstructured":"Verheul HM , HoekmanK, Luykx-deBakker Set\u00a0al.: Platelet: transporter of vascular endothelial growth factor. Clin. Cancer Res. 3,2187\u20132190 (1997).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-200209000-00005"},{"key":"e_1_3_1_32_1","first-page":"46","article-title":"Antimetastatic effect associated with platelet reduction.","volume":"61","author":"Gasic GJ","year":"1998","unstructured":"Gasic GJ , GasicTB, StewartCC: Antimetastatic effect associated with platelet reduction.Pathology61,46\u201352 (1998).","journal-title":"Pathology"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113411"},{"key":"e_1_3_1_34_1","first-page":"2824","article-title":"Multiple roles for platelet GPIIb\/IIIa and \u03b1v\u03b23 integrins in tumor growth, angiogenesis, and metastasis","volume":"62","author":"Trikha M","year":"2002","unstructured":"Trikha M , ZhouZ, TimarJet\u00a0al.: Multiple roles for platelet GPIIb\/IIIa and \u03b1v\u03b23 integrins in tumor growth, angiogenesis, and metastasis. Cancer Res.62,2824\u20132833 (2002).","journal-title":"Cancer Res."},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-20564"},{"key":"e_1_3_1_36_1","first-page":"32","article-title":"Prevention of venous thromboembolism in cancer using low molecular weight heparin","volume":"27","author":"Kakkar AJ","year":"1997","unstructured":"Kakkar AJ , WilliamsonRC. Prevention of venous thromboembolism in cancer using low molecular weight heparin. Haemostasis 27,32\u201337 (1997).","journal-title":"Haemostasis"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615131"},{"key":"e_1_3_1_38_1","first-page":"815","article-title":"Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: a prospective randomized double-blind trial","volume":"16","author":"von Tempelhoff GF","year":"2000","unstructured":"von Tempelhoff GF , HarenbergJ, NeimannFet\u00a0al.: Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: a prospective randomized double-blind trial. Int. Oncol.16,815\u2013824 (2000).","journal-title":"Int. Oncol."},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(02)00258-6"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.15.1729"},{"key":"e_1_3_1_41_1","first-page":"654","volume-title":"Clinique de l\u2018Hotel-Dieu de Paris","author":"Trousseau A.","year":"1865","unstructured":"Trousseau A. Plegmasia alba dolens. In: Clinique de l\u2018Hotel-Dieu de Paris, 2nd Edn. In BaillierJB (Ed.) London: New Syndenham Society3,654\u2013712 (1865).","edition":"2"},{"key":"e_1_3_1_42_1","first-page":"650","article-title":"Phlebitis and thrombosis.","volume":"1","author":"Haward W","year":"1906","unstructured":"Haward W : Phlebitis and thrombosis.Lancet1,650\u2013655 (1906).","journal-title":"Lancet"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(87)80010-2"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(02)00045-2"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00046905"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.1.1.1"},{"key":"e_1_3_1_47_1","first-page":"52","article-title":"Chemistry of heparin and low molecular weight heparin","volume":"543","author":"Nielsen JI","year":"1988","unstructured":"Nielsen JI , OstergaardP: Chemistry of heparin and low molecular weight heparin. Acta. Chir. Scand. Suppl.543,52\u201356 (1988).","journal-title":"Acta. Chir. Scand. Suppl."},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<257::AID-CNCR1>3.0.CO;2-2"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996417"},{"key":"e_1_3_1_50_1","first-page":"755","volume-title":"Drugs of the Future","author":"Mousa SA","year":"2004","unstructured":"Mousa SA , KaiserB: Tissue factor pathway inhibitor in thrombosis and beyond.Drugs of the Future29(7), 755766 (2004)."},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204093261502"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90008-6"},{"key":"e_1_3_1_53_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612043453531"},{"key":"e_1_3_1_54_1","first-page":"683","article-title":"Antiangiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anticancer efficacy.","volume":"12","author":"Mousa SA","year":"2004","unstructured":"Mousa SA , MohamedS: Antiangiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anticancer efficacy.Oncol. Rep. 12,683\u2013688 (2004).","journal-title":"Oncol. Rep."},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-2444-5_34"},{"key":"e_1_3_1_56_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH04-02-0069"},{"key":"e_1_3_1_57_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00341.x"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-1054"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-994919"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1004408"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-199603050-00008"},{"key":"e_1_3_1_62_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.03971.x"},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)05095-8"},{"key":"e_1_3_1_64_1","first-page":"579","article-title":"Fibrinogen-fibrin transformation in\u00a0situ in renal cell carcinoma","volume":"10","author":"Wojtukiewicz M","year":"1990","unstructured":"Wojtukiewicz M , ZacharskiL, MemoliVet\u00a0al.: Fibrinogen-fibrin transformation in\u00a0situ in renal cell carcinoma. Anticancer Res.10,579\u2013582 (1990).","journal-title":"Anticancer Res."},{"key":"e_1_3_1_65_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1002415"},{"key":"e_1_3_1_66_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117451"},{"key":"e_1_3_1_67_1","first-page":"327","article-title":"Actions of heparin in the atherosclerotic process.","volume":"48","author":"Engelberg H","year":"1996","unstructured":"Engelberg H : Actions of heparin in the atherosclerotic process.Pharmacol. Rev.48,327\u2013352 (1996).","journal-title":"Pharmacol. Rev."},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.2.2.227"},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.1159\/000046583"},{"key":"e_1_3_2_2_1","article-title":"Prevention and treatment of tumor growth, metastsis, and thrombembolic complications in cancer patients","author":"El-Naggar M","year":"2004","unstructured":"El-Naggar M , MousaSA: Prevention and treatment of tumor growth, metastsis, and thrombembolic complications in cancer patients. US Patent 0214751 (2004).","journal-title":"US Patent 0214751"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14796694.1.3.395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:40:53Z","timestamp":1719124853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14796694.1.3.395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1517\/14796694.1.3.395"],"URL":"https:\/\/doi.org\/10.1517\/14796694.1.3.395","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}